Unfortunately for some shareholders, the Aurora Cannabis Inc. (TSE:ACB) share price has dived 26% in the last thirty days, prolonging recent pain. The recent drop has obliterated the annual return, with the share price now down 4.9% over that longer period.
Although its price has dipped substantially, it’s still not a stretch to say that Aurora Cannabis’ price-to-sales (or “P/S”) ratio of 0.9x right now seems quite “middle-of-the-road” compared to the Pharmaceuticals industry in Canada, where the median P/S ratio is around 0.7x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.
View our latest analysis for Aurora Cannabis
What Does Aurora Cannabis’ P/S Mean For Shareholders?
Aurora Cannabis’ revenue growth of late has been pretty similar to most other companies. The P/S ratio is…
